Xenobiotica 1997-11-01

Comutagenesis-III. In vitro metabolism of 2-amino-3-methylpyridine: the effect of various potential inhibitors, activators and inducers.

Yuting Zhao, Dan Du, Yuehe Lin

文献索引:Xenobiotica 27(11) , 1103-11, (1997)

全文:HTML全文

摘要

1. The effects of various potential inhibitors, activators and inducers on the metabolism of the comutagen 2-amino-3-methylpyridine (2A3MP) by rabbit hepatic microsomes and S9 supernatants have been studied. 2. The 1-N-oxidation of 2A3MP to 2-amino-3-methylpyridine-1-N-oxide (2A3M-PNO) was inhibited by 2,4-dichloro-6-phenylphenoxyethylamine (DPEA), 2-diethylaminoethyl-2,2-diphenylvalerate (SKF 525-A) and n-octylamine. 3. The C-oxidation products of 2A3MP, i.e. 2-amino-3-hydroxymethylpyridine (2A3HMP) and 2-amino-3-methyl-5-hydroxypyridine (2A3M5HP), were also inhibited by these compounds. 4. Pretreatment of animals with phenobarbitone (PB) resulted in an increase in the production of 2A3MPNO and 2A3HMP, whereas beta-naphthoflavone (BNF) pretreatment had a greater effect on the formation of 2A3M5HP. 5. Pretreatment with pyridine or pyrazine also had an appreciable effect on the formation of 2A3HMP. 6. It is suggested that different cytochrome P450 isozymes are responsible for the metabolic profile of 2A3MP. CYP2B was involved in the N-oxidation; 2E and/or 2B in the formation of 2A3HMP, and 3A and/or 1A in the formation of 2A3M5HP.


相关化合物

  • 2-氨基-3-甲基吡啶

相关文献:

Synthesis and characterisation of two novel proton transfer compounds and their inhibition studies on carbonic anhydrase isoenzymes.

2011-02-01

[J. Enzyme Inhib. Med. Chem. 26(1) , 104-14, (2011)]

Comutagenesis-I: the in vitro metabolism of 2-amino-3-methylpyridine.

1997-01-01

[Anticancer Res. 17(5A) , 3485-91, (1997)]

Comutagenesis-IV in vitro metabolism of the comutagen 2-amino-3-methylpyridine: species differences and metabolic interaction with norharman.

1997-01-01

[Anticancer Res. 17(6D) , 4479-82, (1997)]

Comutagenesis--V: rapid conversion of 2-hydroxyl-amino-3-methylpyridineto 2-amino-3-methylpyridine by a hepatic S9 preparation.

1997-01-01

[Eur. J. Drug Metab. Pharmacokinet. 22(4) , 341-4, (1997)]

更多文献...